Atopic dermatitis (AD), often called eczema, is a chronic inflammatory skin condition that causes itching, dryness, and skin inflammation. While the condition affects people of all backgrounds, research shows that Black, Indigenous, and People of Color (BIPOC) may experience unique challenges related to diagnosis, symptom presentation, and access to care.
Understanding these differences is important for improving treatment, awareness, and research participation.
How Atopic Dermatitis Appears on Different Skin Tones
One challenge in diagnosing atopic dermatitis in BIPOC patients is that symptoms may appear differently on darker skin tones.
Many medical textbooks historically showed eczema primarily on lighter skin, where inflammation often appears red or pink. However, on darker skin tones, eczema may look different, including:
- Purple, gray, or dark brown patches instead of red
- Thickened skin (lichenification) from chronic scratching
- Small raised bumps known as papular eczema
- Changes in skin pigmentation after flare-ups
Because these visual differences have not always been widely taught, some patients with darker skin may experience delayed diagnosis or misdiagnosis.
Higher Burden of Disease in Some Communities
Studies suggest that Black children in the United States are more likely to develop atopic dermatitis and may experience more severe disease compared with some other populations.
Several factors may contribute to this, including:
- Genetic differences in skin barrier function
- Environmental exposures
- Differences in access to dermatology care
- Social and economic factors that affect healthcare access
While researchers are still studying the exact causes, it is clear that the burden of disease can be significant.
Post-Inflammatory Pigmentation Changes
Another important issue for many patients with darker skin tones is post-inflammatory hyperpigmentation (PIH) or hypopigmentation after eczema flares.
When inflammation heals, the skin may become darker or lighter than the surrounding area. These pigmentation changes can last for months and may cause emotional distress or concerns about appearance.
For some patients, these changes can be just as frustrating as the eczema itself.
Why Representation in Clinical Research Matters
Historically, BIPOC populations have been underrepresented in many clinical trials. When diverse populations are not included in research, it can limit understanding of how treatments perform across different skin types and communities.
Increasing diversity in clinical trials helps researchers:
- Understand how treatments work in different populations
- Identify differences in symptom presentation
- Improve treatment guidelines for all patients
- Ensure new therapies are effective across diverse groups
Greater representation ultimately helps make medical research more inclusive and more accurate.
Moving Toward More Inclusive Care
Today, there is growing recognition of the importance of diversity in dermatology and clinical research. Efforts are underway to improve medical education, increase representation in clinical trials, and expand access to dermatologic care.
For people living with atopic dermatitis, these changes are helping move the field toward more personalized and equitable care for patients of all backgrounds.